• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EXPRESS LD VASCULAR; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EXPRESS LD VASCULAR; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number 20212
Device Problems Positioning Failure (1158); Device Dislodged or Dislocated (2923); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/21/2024
Event Type  malfunction  
Manufacturer Narrative
E1 initial reporter facility name: (b)(6) hospital.E1 initial reporter address 1: (b)(6).
 
Event Description
It was reported that stent moved from balloon occurred.Vascular access was obtained via the right femoral artery.The target lesion was located in the subclavian artery.A 6f long sheath was placed, and a 260cm non-boston scientific guidewire was delivered in the lesion.A 5mmx40mm mustang balloon catheter was advanced for pre-dilation, then an 8.0x30x135cm express-vascular ld stent prepared and reached the lesion.During the procedure, the pressure was prepared for deployment.However, under digital subtraction angiography (dsa), the balloon expanded, but the stent slightly moves to the tip of the balloon but did not move out from the balloon.The pressure was removed and withdraw the device, it was confirmed the device could no longer be used.The procedure was completed with another of the same device.No complications were reported, and the patient was stable.
 
Event Description
It was reported that stent moved from balloon occurred.Vascular access was obtained via the right femoral artery.The target lesion was located in the subclavian artery.A 6f long sheath was placed, and a 260cm non-boston scientific guidewire was delivered in the lesion.A 5mmx40mm mustang balloon catheter was advanced for pre-dilation, then an 8.0x30x135cm express-vascular ld stent prepared and reached the lesion.During the procedure, the pressure was prepared for deployment.However, under digital subtraction angiography (dsa), the balloon expanded, but the stent slightly moves to the tip of the balloon but did not move out from the balloon.The pressure was removed and withdraw the device, it was confirmed the device could no longer be used.The procedure was completed with another of the same device.No complications were reported, and the patient was stable.
 
Manufacturer Narrative
E1: initial reporter facility name: (b)(6) hospital.E1: initial reporter address 1: (b)(6).Device evaluated by mfr.: visual examination identified that the stent had almost completely separated distally from the balloon catheter and was damaged along the entire length of the stent.Further examination identified that the balloon had been subjected to positive pressure indicating that stent deployment had been attempted.No issues were noted with the balloon material.A visual examination identified no issues with the tip or shaft of the device.The unreported stent damage noted during device analysis most likely occurred due to an interaction between the user and the device (unintended), at which stage of the procedure it occurred (during procedure/handling post procedure) cannot be established.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EXPRESS LD VASCULAR
Type of Device
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18887163
MDR Text Key337458106
Report Number2124215-2024-14337
Device Sequence Number1
Product Code FGE
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number20212
Device Catalogue Number20212
Device Lot Number0031714098
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/22/2024
Initial Date FDA Received03/12/2024
Supplement Dates Manufacturer Received04/05/2024
Supplement Dates FDA Received05/02/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/30/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age67 YR
Patient SexFemale
Patient Weight60 KG
-
-